Alarming burden of Dual-Class HIV-1 Drug Resistance among Adolescents calls for innovative Antiretroviral Strategies: Baseline findings from the Ready-Study (EDCTP TMA 1027)

INTEREST 2020

Ethical Engagement of AGYW in Global Fund GC7 Process_AGYW Perspectives From Eswatini, Lesotho, Malawi, Mozambique, and Zimbabwe - Chrystal Bonzo.pdf

International Workshop on HIV & Adolescence 2023

#21- Hospital Outcomes From a Cohort of Mozambican HIV-Exposed Uninfected and HIV-Unexposed Infants - Chris Buck

International Workshop on Pediatrics & HIV 2024

#3 - An Integrated HIV-geriatric Clinic Model: Lessons from Newlands Clinic, Harare, Zimbabwe - Sara Lowe

International Workshop on HIV & Aging 2023

How to Reduce OIs and AIDS Deaths in Southeast Asia from the WHO, Nathan Ford, MPH, PhD, FRCPE

APACC 2023

How to Reduce OIs and AIDS Deaths in Southeast Asia from the WHO, Nathan Ford, MPH, PhD, FRCPE

APACC 2023

Can Integration Reduce Stigma? / Lessons Learned from HIV - Danjuma Adda, MPH, FIMS, Dip-IMS

Conference on Liver Disease in Africa (COLDA) 2022

Immune Correlates of Protection from SARS-CoV-2 Infection | Miles Philip Davenport, MB BS, D.Phil

International Workshop on COVID-19 Vaccines 2022 - June Edition

SARS-CoV-2 Evolution: Where Do We Go From Here? | Jacob E. Lemieux, MD, DPhil

COVID-19 Clinical Forum 2022

Dolutegravir Plus Lamivudine Dual Therapy in Treatment naïve HIV-1 patients：Preliminary Data from Real-world

APACC 2021